Journal article
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients Aged >90 Years Versus <90 Years
J Stehli, JQS Koh, SJ Duffy, J Zamani, CC Yeong, E Paratz, C Martin, NM Htun, D Stub, R Dick, A Walton
American Journal of Cardiology | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | Published : 2019
Abstract
Limited data exist regarding transcatheter aortic valve implantation (TAVI) in nonagenarians. This study evaluates the short- and mid-term outcomes of nonagenarians after TAVI. Between 2008 and 2017, all patients who underwent TAVI in 2 centers in Australia were prospectively included in a registry and followed-up for 5 years. Outcomes were based on VARC-2 criteria. Additionally, the patient's reliance on daily living support at 1 year was evaluated. Of the 588 patients, 71 (12.1%) were ≥90 years old (mean age 92.2 ± 2 vs 83.2 ± 6 years in <90-year-old patients), with a median STS-PROM score of 5.7 (vs 3.9 in <90-year-old patients, odds ratio [OR] 1.07, 95% confidence interval 1.01 to 1.13, ..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
ASW is proctor for and on the Medical Advisory Board of Medtronic. DS receives a National Heart Foundation Fellowship and Viertel Foundation Award. NMH receives a Royal Australasian College of Physicians Research Establishment Fellowship. SJD is proctor for Medtronic. SJD's work is supported by a National Health and Medical Research Council of Australia grant (no. 1111170). JS has received travel grants and holds stock in Medtronic and Abbott. All other authors have no conflicts of interest.